Peptide Cycle Length: When to Stop, When to Continue
The internet gives wildly different cycle recommendations for the same peptide. Some sources say BPC-157 should never exceed 4 weeks; others recommend 12-week protocols without a break. Here's what the published research and clinical experience actually suggest.
The general principle
Most peptides have a sensible "cycle on / cycle off" pattern because of receptor downregulation, immune-system adaptation, or simply because longer-term safety data doesn't exist. The rules aren't universal — GLP-1s for weight management are clinically dosed indefinitely; nootropic peptides like Selank are explicitly cycled in 10–14 day blocks.
Cycle windows for common peptides
| Peptide | Typical cycle | Off period | Notes |
|---|---|---|---|
| BPC-157 | 4–8 weeks | 2–4 weeks | Recovery focus; longer cycles for chronic injuries |
| TB-500 | 4–6 weeks | 4 weeks | Often loading + maintenance phases |
| Semaglutide | Long-term titrated | N/A in clinical use | FDA-approved chronic use |
| Tirzepatide | Long-term titrated | N/A in clinical use | FDA-approved chronic use |
| Ipamorelin | 8–12 weeks | 4 weeks | To preserve receptor sensitivity |
| CJC-1295 | 8–12 weeks | 4 weeks | Same as ipamorelin (often stacked) |
| GHK-Cu | 12+ weeks | Variable | Lower cycling concern |
| Selank | 10–14 days | 14+ days | Tolerance develops with continuous use |
| Semax | 10–14 days | 14+ days | Same as Selank |
| Epitalon | 10–20 days | ~3 months | Short bursts, repeated quarterly |
Why these numbers vary so much in practice
Three factors drive variance: most "protocols" online aren't from clinical trials, they're aggregated from forum experience reports; individual response varies enormously; goals matter — recovery from acute injury runs different cycles than chronic maintenance.
Tracking cycle endings is what most people get wrong
The single most common error: people start a cycle, log diligently for week 1, then drift. By week 6 they don't remember if they're meant to stop at week 8 or week 12. Peptra solves this by setting cycle endpoints when you start a protocol and surfacing the final week as a clear "cycle ending soon" prompt.